FimmCyte is a pre-clinical stage biotechnology company founded as a spin-off company from the University of Zürich & University Hospital Zürich, Lab of Prof. Brigitte Lerner. FimmCyte’s most advanced program is a non-hormonal disease modifying treatment for endometriosis.
Visit Website